1. Defibrotide is a drug which is a mixture of DNA fragments of variou
s lengths. To characterize the active component which is responsible f
or the fibrinolytic effect, we fractionated defibrotide by column chro
matography and investigated direct and endothelium dependent fibrinoly
tic activity of the major fractions by euglobulin lysis time (ELT) mea
surements. 2. Defibrotide and its fractions added to human plasma samp
les did not change ELT. However addition of conditioned media of human
umbilical vein endothelial cell cultures which were incubated with de
fibrotide or its high molecular weight fractions shortened the ELT sig
nificantly (P < 0.001), whereas small molecular weight fractions did n
ot effect the ELT. 3. Our results show that high molecular weight defi
brotide fractions have fibrinolytic activity and the effect is endothe
lium dependent.